FDA considers a first: approval of drug for inhibiting preterm labor.
D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D008431:Maternal-Fetal Exchange; D007752:Obstetric Labor, Premature / Q000517:prevention & control*; D011247:Pregnancy; D011412:Propanolamines / Q000008:administration & dosage*; D012312:Ritodrine / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D011412:Propanolamines; D012312:Ritodrine